John Alexander Kelly, Chief Financial Officer at PRECISION BIOSCIENCES INC (DTIL), sold 1,303 shares at $6.49 ($8K) on 2025-11-03, disclosed to the SEC on 2025-11-04.
Scheduled sale ($8k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DTIL | SELL | 2025-07-08 | $126K | — | Filing → |
| DTIL | BUY | 2024-12-31 | $10K | — | Filing → |
| DTIL | BUY | 2024-11-21 | $20K | — | Filing → |